Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001035704-99-000146
Filing Date
1999-03-24
Accepted
1999-03-24 00:00:00
Documents
17
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 1998 10-K 192240
2 AMENDED & RESTATED CERTIFICATE OF INCORPORATION EX-3.1 50525
3 STOCK PURCHASE WARRANT EX-4.5 27975
4 1ST AMENDMENT TO AGREEMENT EX-10.3(A) 4440
5 2ND AMENDMENT TO AGREEMENT EX-10.3(B) 5163
6 3RD AMENDMENT TO AGREEMENT EX-10.3(C) 5500
7 4TH AMENDMENT TO AGREEMENT EX-10.3(D) 6874
8 5TH AMENDMENT TO AGREEMENT EX-10.3(E) 3373
9 AMENDED & RESTATED PERFORMANCE STOCK OPTION PLAN EX-10.5 47803
10 NON-QUALIFIED STOCK OPTION PLAN EX-10.6 27033
11 EMPLOYMENT AGREEMENT EX-10.7 8018
12 EMPLOYMENT AGREEMENT EX-10.8 7619
13 FORM OF PERSONAL SERVICES AGREEMENT EX-10.9 31955
14 PERSONAL SERVICES EX-10.10 34881
15 SUBSIDIARIES OF THE REGISTRANT EX-21 175
16 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS EX-23 586
17 FINANCIAL DATA SCHEDULE EX-27 2055
  Complete submission text file 0001035704-99-000146.txt   459485
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18231 | Film No.: 99571050
SIC: 2834 Pharmaceutical Preparations